Skip to main content

DarioHealth Corp

For the period ended Dec 31, 2023. Filed Mar 28, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 28, 2024

DRIO$2.06-13.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 28, 2024DARIOHEALTH CORP.
By:/s/ Erez Raphael
Name:Erez Raphael
Title:Chief Executive Officer
By:/s/ Zvi Ben David
Name:Zvi Ben David
Title:Chief Financial Officer, Secretary and Treasurer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

PersonCapacityDate
/s/ Erez RaphaelChief Executive Officer andMarch 28, 2024
Erez RaphaelDirector (Principal Executive Officer)
/s/ Zvi Ben DavidChief Financial Officer, Secretary andMarch 28, 2024
Zvi Ben DavidTreasurer (Principal Financial and Accounting Officer)
/s/ Yoav ShakedChairman of the BoardMarch 28, 2024
Yoav Shaked
/s/ Dennis MatheisDirectorMarch 28, 2024
Dennis Matheis
/s/ Hila KarahDirectorMarch 28, 2024
Hila Karah
/s/ Dennis M. McGrathDirectorMarch 28, 2024
Dennis M. McGrath
/s/ Jon KaplanDirectorMarch 28, 2024
Jon Kaplan
​​​​​
/s/ Adam SternDirectorMarch 28, 2024
Adam Stern

CONSOLIDATED FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2023

INDEX

Page
Report of Independent Registered Public Accounting Firm (PCAOB - Firm ID: 1281)​F-2 – F-4
​
Consolidated Balance Sheets​F-5 – F-6
​
Consolidated Statements of Comprehensive Loss​F-7
​
Statements of Changes in Stockholders’ Equity​F-8
​
Consolidated Statements of Cash Flows​F-9
​
Notes to Consolidated Financial Statements​F-10 – F-49
​​​​​​​​
​Kost Forer Gabbay & Kasierer144 Menachem Begin Road, Building A,Tel-Aviv 6492102, Israel​​Tel: +972-3-6232525Fax: +972-3-5622555ey.com
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.